Thymosin Beta-4 vs IGF-1 DES
Side-by-side comparison of key properties, dosing, and research.
Recovery & RepairAnti-Aging & Longevity
Thymosin Beta-4Anabolic & IGF
IGF-1 DES- Summary
- Thymosin Beta-4 is an endogenous 43-amino acid peptide that is the primary intracellular actin sequestering peptide. It promotes tissue repair, reduces inflammation, regenerates hair follicles, and protects cardiac tissue. Closely related to TB-500 (the active fragment), it is used for systemic tissue recovery and anti-aging.
- IGF-1 DES (also written DES(1-3)IGF-1) is a truncated form of IGF-1 missing the first three amino acids of the N-terminus. This structural change dramatically reduces its affinity for IGF binding proteins (IGFBPs), meaning a far greater fraction remains in its free, active form. IGF-1 DES is estimated to be 10x more potent than standard IGF-1 LR3 at the receptor level locally, making it particularly effective for site-specific muscle growth when injected intramuscularly.
- Half-Life
- Not well characterized; likely similar to TB-500 (~1–2 hours)
- ~20–30 minutes (very short — designed for local action)
- Admin Route
- SubQ, IM
- IM, SubQ
- Research
- —
- —
- Typical Dose
- 5–10 mg
- 20–50 mcg per injection site
- Frequency
- 2x per week (loading), then 1x per week (maintenance)
- Once daily, post-workout
- Key Benefits
- Systemic tissue repair and regeneration
- Promotes cardiac recovery after myocardial infarction
- Hair follicle regeneration and anti-hair-loss
- Anti-inflammatory (systemic)
- Wound healing acceleration
- Neuroprotection after brain injury
- Protects against ischemia-reperfusion injury
- Anti-aging at cellular level
- Synergizes powerfully with BPC-157
- Estimated 10x greater potency at the receptor vs IGF-1 LR3 locally
- Minimal IGFBP binding — nearly all active upon injection
- Highly localized muscle growth effect when injected intramuscularly
- Activates satellite cells for muscle fiber hyperplasia potential
- Synergistic with GH peptides in post-workout anabolic protocols
- Shorter half-life reduces systemic exposure vs IGF-1 LR3
- Useful for site-specific muscle development
- Side Effects
- Generally very well tolerated
- Injection site reactions
- Mild fatigue at initiation (repair signaling)
- Rare: mild inflammatory response
- +1 more
- Hypoglycemia (most significant risk — especially post-workout)
- Localized muscle swelling at injection site
- Potential for jaw/organ growth (acromegalic effects) with prolonged high-dose use
- Carpal tunnel syndrome with high doses
- +1 more
- Stacks With
- —
- —